although
felin
coronaviru
fcov
caus
felin
infecti
periton
fip
fatal
infecti
diseas
effect
therapeut
medicin
vaccin
previous
vitro
studi
shown
cyclosporin
csa
inhibit
viru
replic
divers
coronavirus
csa
target
clinic
relev
immunosuppress
drug
bind
cellular
cyclophilin
cyp
bind
protein
fkbp
respect
cyp
fkbp
peptidylprolyl
cistran
isomeras
ppias
activ
howev
protein
interact
nima
member
parvulin
subfamili
ppias
differ
cyp
fkbp
essenti
variou
signal
pathway
demonstr
genet
silenc
knockout
result
decreas
fcov
replic
vitro
dipentamethylen
thiuram
monosulfid
specif
inhibitor
inhibit
fcov
replic
data
indic
modul
fcov
propag
coronavirus
cov
caus
sever
diseas
respiratori
system
gastrointestin
tract
central
nervou
system
anim
perlman
netland
felin
cov
fcov
classifi
two
biotyp
compris
ubiquit
felin
enter
cov
fecv
felin
infecti
periton
viru
fipv
pedersen
felin
infecti
periton
fip
one
frequent
caus
death
young
cat
classic
symptom
effusivewet
fip
noneffusivedri
form
fip
combin
two
develop
berg
et
al
mortal
extrem
high
clinic
sign
appear
although
cat
live
diseas
week
month
even
year
pedersen
nevertheless
fip
current
incur
drug
treatment
effect
prophylact
vaccin
viru
replic
depend
varieti
host
factor
de
haan
rottier
vogel
et
al
zhang
et
al
consequ
repres
potenti
antivir
target
report
cyclosporin
csa
cellular
cyclophilin
cyp
inhibitor
inhibit
fcov
replic
cell
cultur
tanaka
et
al
although
suppress
calcineurin
nuclear
factor
pathway
activ
tcell
nfat
stage
csa
affect
fcov
replic
tanaka
et
al
data
indic
csa
exert
inhibitori
effect
via
nfat
pathway
report
csa
treatment
caus
sustain
reduct
pleural
fluid
volum
viral
copi
number
cat
diagnos
effus
fip
tanaka
et
al
csa
well
known
potent
replic
inhibitor
variou
human
anim
cov
de
wild
et
al
pfefferl
et
al
regard
requir
cyp
cov
replic
use
small
interf
rna
sirna
experi
de
wild
et
al
report
cypa
cypb
affect
sever
acut
respiratori
syndrom
cov
sarscov
replic
de
wild
et
al
contrast
human
cov
replic
depend
cypa
cypb
carbajolozoya
et
al
inhibit
human
cov
sarscov
carbajolozoya
et
al
cov
requir
differ
immunophilin
describ
cyp
fkbp
two
major
famili
peptidylprolyl
cistran
isomeras
ppias
catalyz
cistran
isomer
prolyl
peptid
bond
preced
prolin
residu
target
clinic
relev
immunosuppress
drug
csa
respect
siekierka
et
al
siekierka
et
al
immunosuppress
activ
drug
unrel
inhibit
ppias
activ
neither
cyp
fkbp
gene
essenti
yaff
et
al
contrast
protein
interact
nima
member
parvulin
subfamili
ppias
differ
cyp
fkbp
essenti
cell
growth
requir
catalyt
compet
ppias
domain
lu
et
al
lu
hunter
catalyt
site
uniqu
among
ppias
enzym
recogn
unusu
phosphoryl
serthrepro
motif
substrat
lu
zhou
lu
et
al
wulf
et
al
play
import
role
mani
cellular
event
includ
cell
cycl
progress
cell
prolifer
transcript
regul
neoplasm
transform
protein
link
sever
diseas
cancer
alzheim
diseas
asthma
lu
zhou
regard
infecti
diseas
directli
interact
hepat
c
viru
hcv
protein
play
uniqu
role
hcv
replic
lim
et
al
modul
human
immunodefici
viru
infect
interact
capsid
protein
uncoat
regul
misumi
et
al
watashi
et
al
howev
report
explor
role
cov
replic
present
studi
examin
role
fcov
replic
conclus
report
facilit
replic
fcov
specif
inhibitor
inhibit
viru
replic
protein
express
vitro
therefor
may
potenti
target
fip
treatment
well
cyp
feli
catu
whole
american
type
cultur
collect
va
usa
cell
maintain
dulbecco
modifi
eagl
medium
dmem
sigmaealdrich
tokyo
japan
supplement
fetal
bovin
serum
life
technolog
tokyo
japan
propag
fip
viru
fcov
strain
gift
dr
tsutomu
hodatsu
kitasato
univers
japan
cell
purifi
virion
linear
sucros
gradient
ultracentrifug
isol
felin
peptidylprolyl
cistran
isomeras
gene
cell
use
polymeras
chain
reaction
pcr
primer
taccgagctcggatccaccatggcggacgaag
gatatctgcagaattctcactccgtgcgcag
amplif
total
rna
cell
isol
use
isogen
nippon
gene
toyama
japan
accord
manufactur
protocol
rna
revers
transcrib
use
primescript
revers
transcriptas
rt
pcr
kit
takarabio
shiga
japan
complementari
dna
cdna
pin
amplifi
primestar
max
dna
polymeras
takarabio
specif
primer
describ
gene
clone
mychi
vector
invitrogen
tokyo
japan
digest
ecori
bamhi
restrict
enzym
use
infus
hd
clone
kit
takarabio
accord
manufactur
protocol
sequenc
clone
vector
confirm
bigdy
sequenc
analysi
appli
biosystem
japan
tokyo
japan
genet
knockout
ko
experi
cell
construct
plasmid
use
system
briefli
synthes
oligonucleotid
guid
rna
target
dna
tabl
subclon
vector
bb
addgen
cambridg
usa
sequenc
construct
plasmid
confirm
use
bigdy
termin
cycl
sequenc
kit
life
technolog
ca
usa
cell
seed
day
prior
transfect
well
plate
plasmid
vector
contain
cmyctag
gene
transfect
cell
use
xtreme
hd
transfect
reagent
roch
diagnosi
tokyo
japan
accord
manufactur
instruct
empti
vector
transfect
cell
normal
total
amount
dna
per
transfect
cell
transfect
plasmid
infect
fcov
multipl
infect
moi
plaqueform
unit
pfu
per
cell
order
studi
effect
fcov
infect
h
transfect
infect
cell
collect
incub
use
analysi
assay
evalu
cytotox
dipentamethylen
thiuram
monosulfid
dtm
mp
biomed
llc
solon
oh
usa
cell
use
cell
count
dojin
chemic
inc
wako
japan
accord
manufactur
instruct
cell
incub
without
variou
concentr
dtm
interferon
ifn
u
intercat
toray
tokyo
japan
min
c
inocul
cell
fcov
moi
pfu
per
cell
studi
effect
fcov
infect
adsorpt
h
c
medium
contain
viru
remov
cell
rins
three
time
phosphatebuff
salin
pb
incub
without
variou
concentr
dtm
ifnu
h
analysi
western
blot
quantit
qrtpcr
assay
cell
infect
moi
pfu
per
cell
incub
without
dtm
medium
remov
h
postinfect
rnaisoplu
takara
bio
ad
cell
rna
prepar
accord
manufactur
protocol
total
rna
quantifi
use
one
step
primescript
rtpcr
kit
perfect
real
time
takarabio
viral
cdna
quantifi
realtim
pcr
use
forward
revers
primer
fcovn
gene
taqman
probe
reaction
mixtur
prepar
accord
manufactur
protocol
sequenc
amplifi
use
sequenc
detect
system
appli
biosystem
tokyo
japan
cdna
fcovn
gene
clone
vector
invitrogen
serial
dilut
provid
standard
fcov
gene
quantif
viral
rna
copi
number
normal
use
felin
gene
genbank
access
gene
deriv
cell
clone
pcr
amplif
use
follow
primer
tabl
oligonucleotid
sequenc
singl
guid
rna
target
gene
oligonucleotid
sequenc
amplifi
pcr
product
subclon
plasmid
biodynam
laboratori
inc
tokyo
japan
provid
standard
gene
quantifi
felin
gene
realtim
pcr
use
forward
revers
primer
gene
detect
gene
use
taqman
probe
sirna
duplex
sigmaealdrich
tokyo
japan
felin
use
silenc
express
cell
sequenc
sirna
shown
tabl
nontarget
sirna
bioneer
corpor
daejeon
republ
korea
use
monitor
transfect
knockdown
effici
transfect
cell
cell
per
well
cluster
transfect
optimem
reducedserum
medium
life
technolog
contain
nm
sirna
use
xtremesirna
transfect
reagent
roch
diagnosi
tokyo
japan
cell
infect
fcov
h
post
transfect
pt
moi
pfu
per
cell
infect
cell
collect
h
pt
analyz
western
blot
rtqpcr
titrat
construct
plasmid
transfect
cell
xtreme
hd
transfect
reagent
cell
line
clone
select
puromycin
mgml
period
week
mutat
cell
line
confirm
western
blot
analysi
genom
dna
sequenc
analysi
ko
cell
infect
fcov
strain
moi
pfu
per
cell
studi
effect
fcov
infect
cell
collect
western
blot
rtqpcr
analysi
h
post
infect
luciferas
activ
quantifi
use
promega
tokyo
japan
vector
promot
promega
nfat
respons
assay
report
assay
proceed
use
dualluciferas
report
assay
system
promega
two
report
plasmid
cotransfect
cell
without
mgml
phorbol
pma
sigmaealdrich
tokyo
japan
mgml
ionomycin
sigmaealdrich
stimul
calcium
signal
assay
total
cell
lysat
prepar
report
lysi
buffer
provid
dualluciferas
report
assay
system
h
pt
assay
luciferas
activ
quantifi
triplic
assay
use
lumat
system
berthold
technolog
tokyo
japan
cell
membran
disrupt
cell
lysi
buffer
mm
trisehcl
ph
mm
ethylenediamin
tetraacet
acid
edta
nacl
includ
complet
mini
roch
diagnost
tokyo
japan
h
infect
cell
lysat
resolv
electrophoresi
supersep
gel
wako
tokyo
japan
western
blot
immobilonp
membran
millipor
tokyo
japan
nonspecif
protein
bind
block
nonfat
dri
milk
membran
incub
primari
antibodi
antifcov
nucleocapsid
n
antibodi
mybiosourc
ca
usa
anticmyc
antibodi
santa
cruz
biotechnolog
ca
usa
antibodi
cell
signal
technolog
tokyo
japan
anticyp
b
thermo
fisher
scientif
yokohama
japan
antiglyceraldehyd
dehydrogenas
gapdh
calbiochem
ca
usa
h
antigen
signal
visual
react
protein
membran
horseradish
peroxidaseconjug
antimous
igg
antibodi
promega
andor
antirabbit
igg
antibodi
promega
follow
enhanc
chemiluminesc
substrat
supersign
west
femto
maximum
sensit
substrat
thermo
fisher
scientif
accord
manufactur
protocol
inhibitori
concentr
ic
calcul
r
cran
softwar
drc
packag
statist
signific
determin
use
student
test
data
analyz
signific
threshold
p
assum
valu
express
figur
mean
standard
deviat
sd
analyz
effect
fcov
replic
clone
f
catu
gene
cell
predict
sequenc
gene
report
nation
center
biotechnolog
inform
ncbi
nucleotid
databas
genbank
access
sequenc
clone
gene
exactli
predict
nucleotid
sequenc
data
shown
sequenc
analysi
first
cmyctag
gene
transfect
cell
examin
effect
fcov
replic
cell
infect
fcov
rel
viral
n
protein
express
normal
endogen
cypb
protein
fig
b
western
blot
rtqpcr
analysi
show
viru
protein
express
rna
replic
cell
transfect
gene
enhanc
higher
level
mock
transfect
cell
fig
c
report
interact
phosphoryl
form
nfat
inhibit
calcium
depend
activ
nfat
liu
et
al
evalu
effect
calcineurinnfat
pathway
cell
nfat
luciferas
report
plasmid
lucnfatrehygro
normal
control
plasmid
transfect
cell
incub
withwithout
pma
ionomycin
nfat
signal
control
calcium
stimul
therefor
nfat
signal
activ
absenc
pma
ionomycin
iampietro
et
al
shown
fig
nfat
activ
presenc
absenc
express
significantli
differ
result
suggest
enhanc
fcov
replic
express
correl
calcineurinnfat
pathway
forward
revers
forward
revers
forward
revers
forward
revers
forward
revers
verifi
effect
fcov
replic
use
specif
inhibitor
dtm
activ
dtm
known
specif
inhibitor
activ
valu
mm
tatara
et
al
analyz
cell
viabil
carri
cytotox
assay
use
differ
concentr
dtm
treatment
concentr
level
less
mm
show
cellular
toxic
fig
cell
infect
fcov
treat
dtm
express
viral
n
protein
western
blot
analysi
suppress
dtm
treatment
compar
dmso
treatment
fig
rtqpcr
analysi
show
dtm
inhibit
viral
replic
dosedepend
manner
ic
mm
fig
use
dose
mm
dtm
inhibit
equat
approxim
reduct
compar
dmsotreat
cell
data
show
play
import
role
viru
replic
protein
express
addit
examin
effect
ifn
ifn
often
affect
viru
replic
infect
effect
ifnu
iu
fcov
significantli
differ
dmso
treat
cell
fig
data
indic
ifn
treatment
cell
affect
viru
replic
next
confirm
role
viru
replic
use
genet
knockdown
experi
five
kind
sirna
felin
gene
transfect
cell
cell
infect
fcov
greatest
reduct
fcov
n
protein
found
use
sirna
approxim
reduct
second
influenti
sirna
sirna
approxim
reduct
evid
western
blot
analysi
viral
protein
express
normal
gapdh
express
fig
b
infect
cell
treat
dtm
reduct
ratio
much
greater
cell
treat
sirna
therefor
examin
role
gene
method
carri
genet
ko
experi
cell
use
crispr
system
cell
viabil
doubl
time
ko
cell
significantli
differ
parent
cell
data
shown
confirm
protein
express
level
western
blot
analysi
result
show
protein
express
almost
undetect
result
western
blot
rtqpcr
analysi
show
viru
replic
cell
infect
fcov
suppress
approxim
onelog
reduct
compar
infect
parent
cell
fig
b
data
indic
protein
play
import
role
fcov
replic
chaperon
protein
regul
protein
fold
well
cyp
howev
catalyt
site
uniqu
among
ppias
enzym
recogn
unusu
phosphoryl
serthrepro
motif
substrat
lu
zhou
lu
et
al
wulf
et
al
tri
use
dtm
studi
specif
inhibit
activ
vitro
dtm
inhibit
fcov
replic
dosedepend
manner
result
compat
result
experi
fig
nfat
signal
cell
respond
ionomycinpma
stimul
overexpress
result
show
cell
respond
nfat
signal
contrari
overexpress
enhanc
fcov
replic
addit
knockout
express
suppress
viral
replic
protein
express
howev
n
protein
express
fcov
complet
inhibit
knockout
fig
studi
data
indic
fcov
replic
affect
activ
also
host
factor
cellular
ppias
examin
hypothesi
studi
need
use
multippias
knockout
cell
system
nevertheless
studi
indic
modul
fcov
replic
date
direct
role
report
affect
cov
replic
n
protein
cov
form
helic
ribonucleoprotein
structur
wrap
genom
rna
grna
rna
chaperon
domain
spencer
hiscox
zuniga
et
al
n
protein
may
particip
discontinu
transcript
subgenom
mrna
sgmrna
deplet
n
replicon
reduc
synthesi
sgmrna
grna
zuniga
et
al
glycogen
synthas
kinas
respons
phosphoryl
serineearginin
sr
rich
motif
conserv
nprotein
mous
hepat
viru
sarscov
fcov
treatment
inhibitor
reduc
phosphoryl
n
protein
reduc
viral
titer
cytopath
effect
wu
et
al
studi
could
show
viral
cellular
protein
interact
complex
regul
fcov
replic
howev
directli
interact
n
protein
protein
fcov
cov
rna
depend
rna
polymeras
experi
data
shown
specul
may
directli
indirectli
regul
function
member
deadbox
protein
famili
knockdown
reduc
quantiti
longer
viral
rna
infecti
bronchiti
viru
ibv
wu
et
al
identifi
member
cellular
interactom
ibvn
protein
emmott
et
al
interact
nonstructur
protein
ibv
identifi
xu
et
al
n
phosphoryl
allow
recruit
phosphorylatedncontain
complex
facilit
templat
readthrough
enabl
longer
sgmrna
synthesi
wu
et
al
howev
evid
regul
function
interact
directli
hcv
protein
play
uniqu
role
hcv
replic
lim
et
al
addit
modul
infect
interact
capsid
protein
uncoat
regul
misumi
et
al
watashi
et
al
csa
shown
exert
inhibitori
effect
herp
simplex
viru
walev
et
al
vaccinia
viru
damaso
keller
bk
polyoma
viru
acott
et
al
billich
et
al
streblow
et
al
hcv
watashi
et
al
report
show
ppias
import
role
replic
variou
virus
well
influenc
uncoat
viral
intern
cell
consid
find
first
time
studi
reveal
essenti
role
fcov
replic
therefor
studi
may
contribut
develop
antifcov
cov
inhibitor
studi
support
grantinaid
scientif
research
c
japan
societi
promot
scienc
error
bar
indic
standard
deviat
asterisk
indic
signific
differ
p
valu
parent
cell
c
total
rna
supernat
infect
cell
treat
describ
legend
panel
extract
analyz
rtqpcr
sampl
assess
triplic
measur
error
bar
indic
standard
deviat
asterisk
indic
signific
differ
p
valu
parent
cell
